K. Nithipatikom et al., Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs, ANALYT BIOC, 292(1), 2001, pp. 115-124
Arachidonic acid (AA) can be metabolized by cytochrome P450 enzymes to many
biologically active compounds including 5,6-, 8,9-, 11,12-, and 14,15-epox
yeicosatrienoic acids (EETs), their corresponding dihydroxyeicosatrienoic a
cids (DHETs), as well as 19- and 20-hydroxyeicosatetraenoic acids (HETEs).
These eicosanoids are potent regulators of vascular tone. However, their ro
le in the ischemic myocardium has not been well investigated, In this study
, we used a gas chromatographic-mass spectrometric technique to analyze tot
al EETs, DHETs, and SO-METE released into coronary venous plasma during cor
onary artery occlusion and reperfusion in anesthetized dogs. Pentafluoroben
zyl esters (PFB-esters) of EETs and PFB-esters/trimethylsilyl ethers (TMS e
thers) of DHETs and SO-METE were detected in the negative ion chemical ioni
zation (NICI) using methane as a reagent gas. Under the conditions used, al
l four regioisomers of EET eluted from the capillary gas chromatographic co
lumn at similar retention times while four regioisomers of DMETs and 80-HET
E eluted separately. The detection limits in plasma samples are 5 pg for to
tal EETs, 40 pg for DHET, and 15 pg for SO-METE. 14,15-DHET is the major re
gioisomer detected in the plasma samples while other regioisomers of DHETs
are probably present at too low a concentration for detection. During the f
irst 5 to 15 min of coronary occlusion, a slight decrease in the concentrat
ion of EETs, 14,15-DHET, and 20-HETE from the control values was observed i
n coronary venous plasma. At 60 min of occlusion, their concentrations sign
ificantly increased and remained elevated during 5 to 60 min of reperfusion
. The concentrations decreased at 120 min of reperfusion, The NICI G:C-MS w
as successfully used as a sensitive technique to determine cP450 metabolite
s of AA in plasma during prolonged occlusion-reperfusion periods. Furthermo
re, the results indicate that these metabolites may play a role in mediatin
g ischemic-reperfusion injury. (C) 2001 Academic Press.